Surveillance programmes for neoplasia in colitis.
Patients with longstanding extensive colitis, both ulcerative colitis and Crohn's colitis, have an increased risk of developing colorectal cancer. Because of this risk, colonoscopic surveillance for neoplasia is recommended by most authorities. Although there has been no randomised controlled trial to demonstrate surveillance effectiveness, there are several retrospective comparative studies, which suggest that surveillance reduces colorectal cancer mortality. Over the past decade there have been a number of developments in our understanding of colitis cancer. We have discovered that the severity of colorectal inflammation is an important risk factor, in addition to other known risk factors such as the extent and duration of colitis, primary sclerosing cholangitis and a family history of colorectal cancer. Endoscopic techniques have also improved and evidence now demonstrates that pancolonic chromoendoscopy yields significantly more intraepithelial neoplasia than random biopsies. Endoscopic resection of well-circumscribed lesions is now also recognised as being an appropriate strategy, potentially reducing the number of patients requiring colectomy. It is hoped that such developments will further improve the effectiveness of colitis surveillance.
Rutter
Matthew D
MD
Tees Bowel Cancer Screening Centre, University Hospital of North Tees, Stockton-on-Tees, Cleveland, TS19 8PE, UK. matt.rutter@nth.nhs.uk
D003093:Colitis, Ulcerative / Q000150:complications / Q000503:physiopathology; D003113:Colonoscopy / Q000379:methods*; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000209:etiology; D003424:Crohn Disease / Q000150:complications / Q000503:physiopathology; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D011159:Population Surveillance; D012307:Risk Factors; D012720:Severity of Illness Index
Gastroenterology. 2007 Mar;132(3):874-82
17383417
Gastroenterology. 1993 Aug;105(2):418-24
8335197
Am J Gastroenterol. 2003 Aug;98(8):1827-33
12907339
Gastroenterology. 1990 Oct;99(4):1021-31
2394325
Am J Gastroenterol. 2008 Sep;103(9):2342-9
18844620
Gastroenterology. 2006 Apr;130(4):1030-8
16618396
Gut. 2004 Dec;53(12):1813-6
15542520
Lancet. 1990 Aug 11;336(8711):357-9
1975343
Histopathology. 1988 Oct;13(4):385-97
3220464
Gastroenterology. 2004 Feb;126(2):451-9
14762782
Gastroenterology. 1994 Oct;107(4):934-44
7926483
Scand J Gastroenterol. 1996 Dec;31(12):1195-204
8976012
Gastroenterology. 2003 Apr;124(4):880-8
12671882
Gut. 2008 Feb;57(2):196-204
18192453
Gut. 1998 May;42(5):711-4
9659169
Endoscopy. 2005 Dec;37(12):1186-92
16329015
Gastroenterology. 1982 Jul;83(1 Pt 1):36-43
7075944
Gastroenterology. 2006 Jun;130(7):1941-9
16762617
Gastroenterology. 2007 Oct;133(4):1099-105; quiz 1340-1
17919486
Br J Surg. 1994 May;81(5):689-91
8044548
N Engl J Med. 1990 Nov 1;323(18):1228-33
2215606
Gut. 2001 Apr;48(4):526-35
11247898
Gastroenterology. 2001 May;120(6):1356-62
11313305
Lancet. 1994 Jan 8;343(8889):71-4
7903776
Gut. 2010 May;59(5):666-89
20427401
Clin Gastroenterol Hepatol. 2004 Jul;2(7):534-41
15224277
Dis Colon Rectum. 2004 Nov;47(11):1816-23
15622573
Inflamm Bowel Dis. 2006 Aug;12(8):669-76
16917220
Am J Surg Pathol. 1998 Mar;22(3):275-84
9500769
Gastrointest Endosc. 2000 Feb;51(2):123-8
10650251
Gut. 2008 Aug;57(8):1083-9
18367559
Am J Gastroenterol. 1990 Sep;85(9):1083-7
2389720
Gastrointest Endosc. 2002 Jul;56(1):48-54
12085034
Gastroenterology. 1992 Nov;103(5):1611-20
1426881
Br J Cancer. 2009 Nov 17;101(10):1671-5
19826420
Endoscopy. 2007 Mar;39(3):216-21
17385106
Gastrointest Endosc. 2004 Sep;60(3):334-9
15332019
Gut. 2004 Feb;53(2):256-60
14724160
Gut. 2007 Jan;56(1):155-6
17172595
Gut. 1993 Aug;34(8):1075-80
8174957